SIRT1 and cardiac hypertrophy: Similarly, in cardiac MECs, miR-195 expression is increased in response to streptozotocin-induced diabetes, which is associated with reduced SIRT1 levels, impaired myocardial function, oxidative stress, and myocardial hypertrophy, whereas silencing of miR-195 reverses these effects [35].